Who owns the CTX112 trademark?

The CTX112 trademark is owned by CRISPR Therapeutics AG.

What is the serial number for CTX112?

The USPTO serial number for CTX112 is 97371562.

What is the registration number for CTX112?

CTX112 is registered under USPTO registration number 8137640.

CTX

USPTO Trademark Record

REGISTERED

CTX112

Q: What class is the CTX112 trademark registered in?

The CTX112 trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 97371562·Reg 8137640·Filed Apr 20, 2022

Owner CRISPR Therapeutics AG

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CTX112 (Serial No. 97371562), Registration No. 8137640, is a registered US trademark filed on Apr 20, 2022 by CRISPR Therapeutics AG. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: February 10, 2032

Mark Intelligence

CTX112 (Reg. #8137640) is a registered US trademark that has been protecting its owner, CRISPR Therapeutics AG, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 20, 2022

SERIAL

97371562

REG#

8137640

REGISTERED

Feb 10, 2026

Owner

Applicant

CRISPR Therapeutics AG

Entity

Not Provided

Address

Baarerstrasse 14, ZUG V8, 6300

Country

Attorney

NameTiffany D. Gehrke

Law firm

Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP

Docket

33324/60052

Address

233 SOUTH WACKER DRIVE, 6300 WILLIS TOWER, CHICAGO, IL 60606, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 20, 2022

Serial Number97371562

Registration No.8137640

Registration DateFeb 10, 2026

Status DateFeb 10, 2026

Published for OppositionApr 23, 2024

Mark TypeStandard characters

Attorney Docket33324/60052

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Mar 24, 2023

First use in commerce: Mar 24, 2023

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 24, 2023

First use in commerce: Mar 24, 2023

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

54 events

REGISTERED-PRINCIPAL REGISTER

Feb 10, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 10, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 22, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 22, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Jan 05, 2026

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 05, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 05, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jan 02, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jan 02, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

SU - FINAL REFUSAL - WRITTEN

Oct 09, 2025

SU - FINAL REFUSAL - WRITTEN

FINAL REFUSAL E-MAILED

Oct 09, 2025

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 09, 2025

NOTIFICATION OF FINAL REFUSAL EMAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 16, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 16, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 10, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Jun 12, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jun 12, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 12, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO LIE

May 15, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 15, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 15, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 30, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Feb 03, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Feb 03, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 03, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 13, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 11, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Oct 28, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Oct 28, 2024

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 18, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 23, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 23, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 03, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 15, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Feb 16, 2024

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 16, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 16, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Dec 18, 2023

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Dec 18, 2023

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

FINAL REFUSAL WRITTEN

Oct 02, 2023

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 02, 2023

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 02, 2023

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 11, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 10, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 10, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Jul 03, 2023

ASSIGNED TO EXAMINER

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 11, 2023

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 11, 2023

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Feb 14, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 14, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 14, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 07, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 26, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 23, 2022

NEW APPLICATION ENTERED

CTX112

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by CRISPR Therapeutics AG

Other Marks by Tiffany D. Gehrke

Resources

Company